Results for: "ai drug discovery"(4 total found)
“Like most AI pharma pacts, the massive $1.5B headline figure obscures the reality that AstraZeneca is only risking $40M in actual cash upfront, effectively buying a relatively cheap call option on insitro's machine learning models finding viable targets.”
“When a specialized AI model can objectively outperform AlphaFold at mapping cellular binding pockets, traditional SaaS valuation metrics are replaced by pharmaceutical R&D multiples.”
“Generating novel DNA sequences is the easy part of computational biology; Basecamp's actual moat is using AI to solve the physical delivery problem via engineered bacteriophages.”
“Allocating $105M of a $150M raise to human clinical trials versus $20M for AI model training underscores that in computational biotech, wet-lab survival data still dictates unit economics.”